The additional financial provisions support Bayer’s stated goal to get glyphosate litigation and liabilities contained by ...

(Reuters) -German pharmaceutical and biotechnology group Bayer said on Thursday it had set aside an additional 1.2 billion ...

Bayer Aktiengesellschaft boosted 2025 sales outlook with pharma growth and lower litigation costs. Click for why BAYRY is an ...

As cancer lawsuits cut into profits, Roundup-producer Bayer is behind legislation in 12 states and Congress to shield ...

A French court ruled on Thursday that a complaint brought by a family against Bayer claiming their son's disabilities were ...

PROFIT FORECAST: The German pharmaceutical and agricultural conglomerate pre-released preliminary second-quarter numbers last week, announcing group earnings before interest, tax, depreciation, ...

Bayer has applied for approval in the EU of its new herbicide, icafolin, following applications in Brazil, the US, and Canada ...

Bayer, the biotech company and manufacturer of Round Up, has substantially increased its spending on lobbying in Iowa since ...

To combat the onslaught of litigation, Bayer has been pushing legislation in nine states, that would shield the company from ...

In a judgment handed down Thursday, the court ruled that the severe birth defects of Théo Grataloup, now 18, could not be attributed to in utero exposure to glyphosate.

Glyphosate Squeeze Bayer didn’t quantify just how much of an impact it will have on overall production, but says it’s continuing to work diligently with customers to address their needs.

La justice n'a pas reconnu la responsabilité de Bayer-Monsanto dans les malformations du jeune Théo Grataloup, faute de ...